Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Insight & Intelligence™

Back to Item »

IOM Guidelines for Use of Omics Tests in Clinical Trials Add Rigor to Quality Assurance

The report stresses the importance of independent researchers to verify initial biomarker discoveries.

Forward this item to a colleague:
Your name
Your email
(Separate multiple addresses by commas)
 
Colleague's email
(Separate multiple addresses by commas)
 
Personal Message
(optional)
 
 
 

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll